Securities code: Lbx Pharmacy Chain Joint Stock Company(603883) securities abbreviation: Lbx Pharmacy Chain Joint Stock Company(603883) Announcement No.: 2022013
Lbx Pharmacy Chain Joint Stock Company(603883)
Announcement of resolutions of the 11th meeting of the 4th board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
● the board of supervisors has no objection or abstention.
● all the proposals of the board of supervisors meeting were passed.
1、 Meetings of the board of supervisors
Lbx Pharmacy Chain Joint Stock Company(603883) (hereinafter referred to as “the company”) the 11th meeting of the 4th board of supervisors was held by on-site voting on March 6, 2022. Three supervisors should participate in the voting and three supervisors actually participated in the voting. The meeting has gone through appropriate notification procedures. The meeting procedures comply with the provisions of the company law of the people’s Republic of China and other relevant laws and regulations and the articles of association. The meeting and the resolutions adopted are legal and effective.
2、 Deliberation at the meeting of the board of supervisors
The following proposals were considered and adopted at this meeting:
(I) the proposal on changing the implementation location of some raised investment projects was deliberated and adopted
The board of supervisors believes that:
This matter complies with the relevant provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, and the guidelines for the self discipline supervision of listed companies No. 1 – standardized operation of Shanghai Stock Exchange. This change does not change the purpose and investment direction of the raised funds, and there is no situation of changing the investment direction of the raised funds in a disguised form or damaging the interests of shareholders, which is conducive to accelerating the smooth implementation of the investment projects with raised funds and in line with the interests of the company and all shareholders. The board of supervisors agreed to change the implementation location of the company’s raised capital investment project ” Huadong Medicine Co.Ltd(000963) product sorting and processing project”.
See the website of Shanghai Stock Exchange on the same day for details（ http://www.sse.com.cn. ）Announcement of Lbx Pharmacy Chain Joint Stock Company(603883) on changing the implementation location of some raised investment projects (Announcement No.: 2021014).
Voting results: 3 in favor, 0 against, 0 abstention, and passed by vote.
It is hereby announced.
Lbx Pharmacy Chain Joint Stock Company(603883) board of supervisors March 6, 2022
